Role of Real-World Evidence in Clinical Decision-Making for the Management of Advanced Prostate Cancer

被引:0
|
作者
Caveney, Brian [1 ]
机构
[1] Blue Cross & Blue Shield North Carolina, Durham, NC 27707 USA
来源
AMERICAN HEALTH AND DRUG BENEFITS | 2017年 / 10卷 / 03期
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:152 / 154
页数:3
相关论文
共 50 条
  • [21] The Expanding Role of Real-World Evidence Trials in Health Care Decision Making
    Klonoff, David C.
    [J]. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (01): : 174 - 179
  • [22] The evolution of real-world evidence in healthcare decision making
    Williams, David M.
    Evans, Marc
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, 22 (06) : 443 - 445
  • [23] 'Considering the totality of evidence: Combining real-world data with clinical trial results to better inform decision-making
    Mamtani, Ronac
    Lund, Jennifer
    Hubbard, Rebecca A.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (06) : 814 - 816
  • [24] Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea
    Lee, Hankil
    Ahn, Hyeon-Soo
    Kwon, Sol
    Kang, Hye-Young
    Han, Euna
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
  • [25] CONTEXT MATTERS - A TAXONOMY OF REAL-WORLD DATA AND EVIDENCE TO SUPPORT HTA DECISION-MAKING
    Murphy, L. A.
    Mestre-Ferrandiz, J.
    Sola-Morales, O.
    de Pouvourville, G.
    Cunningham, D.
    Corry, S.
    Akehurst, R.
    [J]. VALUE IN HEALTH, 2020, 23 : S622 - S622
  • [26] KEY CONSIDERATIONS FOR EVALUATING REAL-WORLD EVIDENCE IN SUPPORT OF FDA REGULATORY DECISION-MAKING
    Li, Jie
    [J]. INNOVATION IN AGING, 2022, 6 : 193 - 193
  • [27] Early prostate cancer: clinical decision-making
    Jani, AB
    Hellman, S
    [J]. LANCET, 2003, 361 (9362): : 1045 - 1053
  • [28] OPTIMA prostate cancer care pathways - bridging clinical practice guidelines, real world evidence and artificial intelligence to enhance decision-making
    Santiago, Anselmo da Costa I.
    Rivas, Gomez J.
    Maclennan, S.
    Beyer, K.
    Murray, C.
    Smith, E. J.
    Auweter, S.
    Thomas, M.
    Krueger, H.
    N'dow, J.
    Bjartell, A.
    Cornford, P.
    Roobol, M.
    Omar, M. I.
    [J]. EUROPEAN UROLOGY, 2024, 85 : S1885 - S1886
  • [29] Risk assessment in clinical practice: a framework for decision-making in real-world complex systems
    Nathan, Rajan
    Bhandari, Sahil
    [J]. BJPSYCH ADVANCES, 2024, 30 (01) : 53 - 63
  • [30] An SLR of Clinical and Real-World Evidence in Relapsed/Refractory Multiple Myeloma (RRMM) Studies to Inform Clinical Decision-Making in the US
    Forsythe, Anna
    Tomaras, Dimitrios
    Parikh, Kejal
    Copher, Ronda
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E269 - E270